Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
暂无分享,去创建一个
Vicky Goh | Paul Marsden | V. Goh | P. Marsden | D. Landau | G. Cook | M. Siddique | S. Ahmad | S. Chicklore | A. Roy | C. Yip | Connie Yip | Shahreen Ahmad | David Landau | Gary J R Cook | Muhammad Siddique | Sugama Chicklore | Arunabha Roy
[1] Y. Bang,et al. High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy , 2006, Clinical Cancer Research.
[2] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[4] M. Hatt,et al. Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.
[5] M. Hatt,et al. Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET , 2012, The Journal of Nuclear Medicine.
[6] J. Yue,et al. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy. , 2011, European journal of radiology.
[7] J. Matthews,et al. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. , 2005, Lung cancer.
[8] Hyae-Young Kim,et al. Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[9] Robert King,et al. Textural features corresponding to textural properties , 1989, IEEE Trans. Syst. Man Cybern..
[10] Balaji Ganeshan,et al. Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.
[11] Y. Ohno,et al. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. , 2012, AJR. American journal of roentgenology.
[12] L. Trani,et al. A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeks. , 2012, European journal of cancer.
[13] M. Hasegawa,et al. Phantom study on radiotherapy planning using PET/CT--delineation of GTV by evaluating SUV. , 2010, Journal of radiation research.
[14] K. Miles,et al. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.
[15] V. Goh,et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.
[16] F. O’Sullivan,et al. Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome , 2008, Journal of Nuclear Medicine.
[17] Issam El-Naqa,et al. Exploring feature-based approaches in PET images for predicting cancer treatment outcomes , 2009, Pattern Recognit..
[18] W. Oyen,et al. Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer , 2007, Journal of Nuclear Medicine.
[19] K. Shiraishi,et al. Repeat FDG-PET for predicting pathological tumor response and prognosis after neoadjuvant treatment in nonsmall cell lung cancer: comparison with computed tomography. , 2010, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[20] Shoji Kido,et al. Fractal Analysis of Internal and Peripheral Textures of Small Peripheral Bronchogenic Carcinomas in Thin-section Computed Tomography: Comparison of Bronchioloalveolar Cell Carcinomas With Nonbronchioloalveolar Cell Carcinomas , 2003, Journal of computer assisted tomography.
[21] Sang-We Kim,et al. FDG-PET as a Potential Tool for Selecting Patients with Advanced Non–Small Cell Lung Cancer Who May Be Spared Maintenance Therapy after First-Line Chemotherapy , 2011, Clinical Cancer Research.
[22] H. Groen,et al. 18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[23] Baosheng Li,et al. Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[24] S. Jakobsen,et al. PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer , 2011, British Journal of Cancer.
[25] Huan Yu,et al. Coregistered FDG PET/CT-Based Textural Characterization of Head and Neck Cancer for Radiation Treatment Planning , 2009, IEEE Transactions on Medical Imaging.
[26] C. Ramos‐Font,et al. Is FDG‐PET suitable for evaluating neoadjuvant therapy in non‐small cell lung cancer? Evidence with systematic review of the literature , 2010, Journal of surgical oncology.
[27] Joos V Lebesque,et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. , 2005, European journal of cancer.
[28] K. Miles,et al. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.
[29] I. Poon,et al. Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. , 2009, International journal of radiation oncology, biology, physics.
[30] Ronald Boellaard,et al. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[31] Omar S. Al-Kadi,et al. Texture Analysis of Aggressive and Nonaggressive Lung Tumor CE CT Images , 2008, IEEE Transactions on Biomedical Engineering.
[32] C. Dooms,et al. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] J. Bradley,et al. Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.